×
S&P 500   4,158.24 (+2.47%)
DOW   33,212.96 (+1.76%)
QQQ   309.10 (+3.26%)
AAPL   149.64 (+4.08%)
MSFT   273.24 (+2.76%)
FB   195.13 (+1.83%)
GOOGL   2,246.33 (+4.20%)
AMZN   2,302.93 (+3.66%)
TSLA   759.63 (+7.33%)
NVDA   188.11 (+5.38%)
BABA   93.41 (-1.13%)
NIO   16.57 (+3.37%)
AMD   102.26 (+3.55%)
CGC   4.88 (-12.07%)
MU   73.32 (+3.85%)
T   21.29 (-0.14%)
GE   78.76 (+2.27%)
F   13.63 (+3.89%)
DIS   109.32 (+3.51%)
AMC   14.43 (+17.99%)
PFE   53.91 (-0.15%)
PYPL   85.21 (+5.96%)
NFLX   195.19 (+1.98%)
S&P 500   4,158.24 (+2.47%)
DOW   33,212.96 (+1.76%)
QQQ   309.10 (+3.26%)
AAPL   149.64 (+4.08%)
MSFT   273.24 (+2.76%)
FB   195.13 (+1.83%)
GOOGL   2,246.33 (+4.20%)
AMZN   2,302.93 (+3.66%)
TSLA   759.63 (+7.33%)
NVDA   188.11 (+5.38%)
BABA   93.41 (-1.13%)
NIO   16.57 (+3.37%)
AMD   102.26 (+3.55%)
CGC   4.88 (-12.07%)
MU   73.32 (+3.85%)
T   21.29 (-0.14%)
GE   78.76 (+2.27%)
F   13.63 (+3.89%)
DIS   109.32 (+3.51%)
AMC   14.43 (+17.99%)
PFE   53.91 (-0.15%)
PYPL   85.21 (+5.96%)
NFLX   195.19 (+1.98%)
S&P 500   4,158.24 (+2.47%)
DOW   33,212.96 (+1.76%)
QQQ   309.10 (+3.26%)
AAPL   149.64 (+4.08%)
MSFT   273.24 (+2.76%)
FB   195.13 (+1.83%)
GOOGL   2,246.33 (+4.20%)
AMZN   2,302.93 (+3.66%)
TSLA   759.63 (+7.33%)
NVDA   188.11 (+5.38%)
BABA   93.41 (-1.13%)
NIO   16.57 (+3.37%)
AMD   102.26 (+3.55%)
CGC   4.88 (-12.07%)
MU   73.32 (+3.85%)
T   21.29 (-0.14%)
GE   78.76 (+2.27%)
F   13.63 (+3.89%)
DIS   109.32 (+3.51%)
AMC   14.43 (+17.99%)
PFE   53.91 (-0.15%)
PYPL   85.21 (+5.96%)
NFLX   195.19 (+1.98%)
S&P 500   4,158.24 (+2.47%)
DOW   33,212.96 (+1.76%)
QQQ   309.10 (+3.26%)
AAPL   149.64 (+4.08%)
MSFT   273.24 (+2.76%)
FB   195.13 (+1.83%)
GOOGL   2,246.33 (+4.20%)
AMZN   2,302.93 (+3.66%)
TSLA   759.63 (+7.33%)
NVDA   188.11 (+5.38%)
BABA   93.41 (-1.13%)
NIO   16.57 (+3.37%)
AMD   102.26 (+3.55%)
CGC   4.88 (-12.07%)
MU   73.32 (+3.85%)
T   21.29 (-0.14%)
GE   78.76 (+2.27%)
F   13.63 (+3.89%)
DIS   109.32 (+3.51%)
AMC   14.43 (+17.99%)
PFE   53.91 (-0.15%)
PYPL   85.21 (+5.96%)
NFLX   195.19 (+1.98%)
NASDAQ:AXLA

Axcella Health (AXLA) Stock Forecast, Price & News

$1.96
+0.01 (+0.51%)
(As of 05/27/2022 04:00 PM ET)
Add
Compare
Today's Range
$1.94
$1.97
50-Day Range
$1.41
$2.82
52-Week Range
$1.35
$5.90
Volume
31,127 shs
Average Volume
79,011 shs
Market Capitalization
$103.05 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.55
30 days | 90 days | 365 days | Advanced Chart
Receive AXLA News and Ratings via Email

Sign-up to receive the latest news and ratings for Axcella Health and its competitors with MarketBeat's FREE daily newsletter.

Axcella Health logo

About Axcella Health

Axcella Health Inc. operates as a clinical stage biotechnology company in the United States. The company treats complex diseases and enhances health using endogenous metabolic modulator compositions. Its lead product candidates include AXA1665, which is in Phase 2 clinical trial for the reduction in risk of overt hepatic encephalopathy recurrence; and AXA1125 that is in Phase 2b clinical trial for treating non-alcoholic steatohepatitis, as well as in Phase 2a clinical trial for Long COVID therapy for patients. The company was formerly known as Newco LS16, Inc. and changed its name to Axcella Health Inc. in June 2016. Axcella Health Inc. was incorporated in 2008 and is based in Cambridge, Massachusetts.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Biological products, except diagnostic
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:AXLA
Employees
59
Year Founded
N/A

Sales & Book Value

Annual Sales
N/A
Book Value
$0.57 per share

Profitability

Net Income
$-64.63 million
Pretax Margin
N/A

Debt

Price-To-Earnings

Miscellaneous

Free Float
49,159,000
Market Cap
$103.05 million
Optionable
Not Optionable

Company Calendar

Last Earnings
3/30/2022
Today
5/27/2022
Next Earnings (Estimated)
8/04/2022
Fiscal Year End
12/31/2022

MarketRank

Overall MarketRank

2.33 out of 5 stars

Medical Sector

229th out of 1,424 stocks

Biological Products, Except Diagnostic Industry

36th out of 209 stocks

Analyst Opinion: 3.3Community Rank: 4.4Dividend Strength: 0.0Insider Behavior: 3.3Valuation: 0.6 5 -4 -3 -2 -1 -













Axcella Health (NASDAQ:AXLA) Frequently Asked Questions

Is Axcella Health a buy right now?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Axcella Health in the last twelve months. There are currently 1 sell rating, 1 hold rating and 5 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Axcella Health stock.
View analyst ratings for Axcella Health
or view top-rated stocks.

Are investors shorting Axcella Health?

Axcella Health saw a decline in short interest during the month of May. As of May 15th, there was short interest totaling 120,200 shares, a decline of 16.9% from the April 30th total of 144,600 shares. Based on an average trading volume of 74,700 shares, the days-to-cover ratio is currently 1.6 days. Approximately 0.5% of the shares of the company are short sold.
View Axcella Health's Short Interest
.

When is Axcella Health's next earnings date?

Axcella Health is scheduled to release its next quarterly earnings announcement on Thursday, August 4th 2022.
View our earnings forecast for Axcella Health
.

How were Axcella Health's earnings last quarter?

Axcella Health Inc. (NASDAQ:AXLA) released its quarterly earnings results on Wednesday, March, 30th. The company reported ($0.46) EPS for the quarter, missing analysts' consensus estimates of ($0.43) by $0.03. During the same quarter in the previous year, the business posted ($0.40) earnings per share.
View Axcella Health's earnings history
.

What price target have analysts set for AXLA?

7 analysts have issued twelve-month price objectives for Axcella Health's shares. Their forecasts range from $5.00 to $14.00. On average, they anticipate Axcella Health's stock price to reach $8.00 in the next year. This suggests a possible upside of 308.2% from the stock's current price.
View analysts' price targets for Axcella Health
or view top-rated stocks among Wall Street analysts.

Who are Axcella Health's key executives?
Axcella Health's management team includes the following people:
  • Mr. William R. Hinshaw Jr., Pres, CEO & Director (Age 53, Pay $830.23k) (LinkedIn Profile)
  • Dr. Alison D. Schecter M.D., Pres of R&D, Strategy and Operations (Age 58, Pay $525.53k)
  • Mr. Laurent Chardonnet, Consultant (Age 57, Pay $415k)
  • Mr. Robert W. Crane, Sr. VP & CFO (Age 63)
  • Dr. Paul Fehlner J.D., Ph.D., Sr. VP, Chief Legal Officer & Corp. Sec. (Age 58)
  • Ms. Virginia R. Dean, Sr. VP & Chief People Officer (Age 56)
  • Dr. Larry Bell, Global Head of Regulatory Affairs & Pharmacovigilance and Sr. VP
  • Dr. Margaret James Koziel M.D., Sr. VP & Chief Medical Officer (Age 62)
  • Mr. Karim Azer Ph.D., VP of Systems Biology & Discovery
What is Bill Hinshaw's approval rating as Axcella Health's CEO?

3 employees have rated Axcella Health CEO Bill Hinshaw on Glassdoor.com. Bill Hinshaw has an approval rating of 100% among Axcella Health's employees. This puts Bill Hinshaw in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Axcella Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Axcella Health investors own include Sorrento Therapeutics (SRNE), VBI Vaccines (VBIV), Evofem Biosciences (EVFM), ADMA Biologics (ADMA), Coty (COTY), Energy Transfer (ET), Myovant Sciences (MYOV), NVIDIA (NVDA), Pfizer (PFE) and Moderna (MRNA).

When did Axcella Health IPO?

(AXLA) raised $76 million in an initial public offering (IPO) on Thursday, May 9th 2019. The company issued 3,600,000 shares at $20.00-$22.00 per share. Goldman Sachs, J.P. Morgan and SVB Leerink acted as the underwriters for the IPO.

What is Axcella Health's stock symbol?

Axcella Health trades on the NASDAQ under the ticker symbol "AXLA."

Who are Axcella Health's major shareholders?

Axcella Health's stock is owned by many different institutional and retail investors. Top institutional shareholders include Flagship Pioneering Inc. (35.88%), HarbourVest Partners LLC (8.33%), Vanguard Group Inc. (1.44%), Edgewood Management LLC (0.19%), Pinnacle Private Wealth LLC (0.06%) and Cutter & CO Brokerage Inc. (0.04%). Company insiders that own Axcella Health stock include David R Epstein, Des Produits Nestle S Societe, Manu Chakravarthy, Paul Fehlner, Robert Crane and William Hinshaw.
View institutional ownership trends for Axcella Health
.

Which institutional investors are selling Axcella Health stock?

AXLA stock was sold by a variety of institutional investors in the last quarter, including Vanguard Group Inc., and Cutter & CO Brokerage Inc..
View insider buying and selling activity for Axcella Health
or view top insider-selling stocks.

Which institutional investors are buying Axcella Health stock?

AXLA stock was bought by a variety of institutional investors in the last quarter, including Flagship Pioneering Inc., HarbourVest Partners LLC, Edgewood Management LLC, Pinnacle Private Wealth LLC, and Simplex Trading LLC. Company insiders that have bought Axcella Health stock in the last two years include David R Epstein, Des Produits Nestle S Societe, Paul Fehlner, Robert Crane, and William Hinshaw.
View insider buying and selling activity for Axcella Health
or or view top insider-buying stocks.

How do I buy shares of Axcella Health?

Shares of AXLA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Axcella Health's stock price today?

One share of AXLA stock can currently be purchased for approximately $1.96.

How much money does Axcella Health make?

Axcella Health has a market capitalization of $103.05 million. The company earns $-64.63 million in net income (profit) each year or ($1.75) on an earnings per share basis.

How many employees does Axcella Health have?

Axcella Health employs 59 workers across the globe.

What is Axcella Health's official website?

The official website for Axcella Health is www.axcellahealth.com.

How can I contact Axcella Health?

Axcella Health's mailing address is 840 MEMORIAL DRIVE, CAMBRIDGE MA, 02139. The company can be reached via phone at (857) 320-2200, via email at [email protected], or via fax at 617-441-6243.

This page was last updated on 5/27/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.